Full text
PDFPage 1149

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Buchanan C. R., Preece M. A., Milner R. D. Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. BMJ. 1991 Apr 6;302(6780):824–828. doi: 10.1136/bmj.302.6780.824. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Croxson M., Brown P., Synek B., Harrington M. G., Frith R., Clover G., Wilson J., Gajdusek D. C. A new case of Creutzfeldt-Jakob disease associated with human growth hormone therapy in New Zealand. Neurology. 1988 Jul;38(7):1128–1130. doi: 10.1212/wnl.38.7.1128. [DOI] [PubMed] [Google Scholar]
- Harrington M. G., Merril C. R., Asher D. M., Gajdusek D. C. Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. N Engl J Med. 1986 Jul 31;315(5):279–283. doi: 10.1056/NEJM198607313150502. [DOI] [PubMed] [Google Scholar]
- Marzewski D. J., Towfighi J., Harrington M. G., Merril C. R., Brown P. Creutzfeldt-Jakob disease following pituitary-derived human growth hormone therapy: a new American case. Neurology. 1988 Jul;38(7):1131–1133. doi: 10.1212/wnl.38.7.1131. [DOI] [PubMed] [Google Scholar]
- Moura Neto V., Mallat M., Jeantet C., Prochiantz A. Microheterogeneity of tubulin proteins in neuronal and glial cells from the mouse brain in culture. EMBO J. 1983;2(8):1243–1248. doi: 10.1002/j.1460-2075.1983.tb01576.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
